Aptevo Therapeutics falls on Nasdaq letter for non-compliance with listing norm

Aptevo Therapeutics

08/04/2022 20:32

** Drug developer Aptevo Therapeutics' shares  APVO.O  down
8.3% at $5.42 in afternoon trade
    ** APVO gets a letter from Nasdaq indicating that it is not
in compliance with exchange's listing rule as its reported
stockholders' equity of $1.2 million falls short of the minimum
requirement of $2.5 million for continued listing (https://bit.ly/3rd9zz6)
    ** Co says it intends to take all reasonable measures
available to regain compliance with Nasdaq's requirement
    ** Including session's loss, stock down 31% YTD

 (Reporting by Leroy Leo in Bengaluru)
 ((Leroy.Dsouza@thomsonreuters.com ; Twitter: https://twitter.com/LeroyLeo7;))